| Antigen: |
p53 N terminal- linear
epitope aa 20-25. |
| Relevance: |
p53 is a stress-regulated transcription factor that regulates cell cycle arrest and was first identified as an SV40 large T antigen-binding protein. Mutation of p53 is the most common genetic change so far identified in a number of major carcinomas. |
| Clone: |
DO-7 |
| Subclass: |
IgG2b |
| Applications: |
ELISA |
| Immunogen: |
- |
| Reactivity: |
Human |
| Species raised in: |
Mouse |
| Fusion partner: |
- |
| Recommended growth conditions: |
DMEM 5% FCS |
| References: |
Vojtesek B et al. 1992.
J. Immunol. Methods. 151(1-2): 237-44 
Stephen CW et al. 1995. J Mol. Biol. 248(1): 58-78 |
| Notes: |
Positive control: MDA-MB-231
cell line. |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
